DDL provides an annual forum for scientists, academics, clinicians, regulatory and industry specialists involved in developing medicines for inhalation. DDL2017 will have five themed sessions each with a combination of invited and submitted lectures given by experts in the field of inhalation and students working to advance respiratory science.
TTP will be exhibiting, on stand 430, at the Drug Delivery to the Lungs Conference, 6th - 8th December 2017 at the Edinburgh International Conference Centre.
Looking ahead it won’t be about the drug or even the combination of drug and device; with the introduction of value-based healthcare the way in which therapies are evaluated will change. TTP understands this complexity and we are working with our clients to engineer outcomes.
Visit the DDL website here.
Find out more about TTP | engineering outcomes here.
6th - 8th December, Edinburgh International Conference Centre.
The Parenteral Drug Association invites you to join the 14th edition of The Universe of Pre-filled Syringes and Injection Devices!
Since its first edition in 2004, the conference has become a fixture in the calendar for the pharmaceutical industry, and a must-attend event for everyone working in the fields related to parenteral drug and device development. For its 14th year, the European event once again returns to Vienna, one of Europe’s most vibrant cities. By coming to Vienna, you will become part of this cultural melting pot, with unlimited potential for getting involved in the vast professional network of PDA members, speakers and special guests.
TTP has been working with clients to design and develop medical devices for over 30 years. Our multi-disciplinary team has completed multiple parenteral developments for pharma companies with our projects routinely covering front-end innovation and product definition through to industrialisation support. From simple and standalone to...
The Universe of Pre-filled Syringes & Injection Devices, 7-8 November, Austria Center, Vienna
TTP Plc (TTP), a leading independent technology and product development company, and Sphere Fluidics, which provides single cell analysis systems underpinned by its patented picodroplet technology, today announced the launch of the Cyto-Mine® Single Cell Analysis System. The Cyto-Mine system automates single cell analysis, sorting, imaging and dispensing to help boost throughput and sensitivity throughout the biopharmaceutical discovery process.
Sphere Fluidics approached TTP to address the challenges associated with the development of a highly complex laboratory instrument and microfluidic cartridge. In less than three years, the partnership has delivered the Cyto-Mine instrument, based on proprietary algorithm software and optical hardware from Sphere Fluidics, which enables single cell compartmentalisation and fluorescence-assisted sorting. The instrument is compatible with the Cyto-Cartridge®, a disposable microfluidic biochip that integrates Sphere Fluidics’ core technology i...
A novel and disruptive analysis and monoclonal assurance system for drug discovery and development
TTP, based at Melbourn Science Park, have pledged £50,000 a year for the next two years to further help develop the school’s high-quality science teaching, both within the curriculum and outside it.
The partnership, brokered by Melbourn governor Brian Clarkstone, comes as the college marks the dawn of a new era in their science department with a new head, Simon Callow, starting this term and leading a team in which the majority joined the school during 2017.
Simon Holmes, Principal, said “This is a fantastic opportunity to boost the Science experience of our students, both inside and outside lessons. Once we knew the money was confirmed our challenge was to recruit the highest calibre of Science teachers to join our existing staff and move things forwards. With Mr Callow and Dr Wilson, who arrived in January, I am confident we have the lead...
Cohort company SEA, together with TTP plc, has been selected to develop technology designed to improve the efficiency and timely delivery of supplies to frontline battlefield assets.
The technology forms part of the UK MoD’s Defence and Security Accelerator Autonomous Last Mile Re-Supply programme and seeks to provide military logistics specialists with a better understanding of future supply and demand at the frontline, identifying which supplies will be required, where and when.
Such information is crucial in helping to deliver vital supplies quickly and efficiently to maintain operational tempo and enable successful mission outcomes.
The solution proposed by SEA and TTP is based on provision of near real-time usage information of Combat Supplies (CSUPS) through exploitation of the opportunities provided by platforms with an integrated, open architecture and use of a neural net based Demand Forecast expert system to provide a forecast of supply and demand based on the received ...
TTP has been developing cutting edge technologies for the Life Science industry for nearly 3 decades. Our scientists and engineers inhabit the fascinating and endlessly changing intersection between physics, engineering and the biological sciences, spotting opportunities to create new technologies and tools for the advancement of this exciting field.
Our focus areas include: bioprocess (manufacture based on living cells or cell products), human and animal diagnostics, biosensors, and instrumentation for molecular biology and pharmaceutical applications.
In addition to our Life Science expertise we also create disruptive products based on advances in technology and engineering innovation. TTP’s technology lies behind many products and processes in areas as diverse as communications, digital printing, instrumentation, consumer and industrial products, medical devices, cleantech and security systems.
Visit ttpblog.com to find out more.
With the Bridgestone World Solar Challenge (BWSC) drawing closer, Cambridge University Eco Racing (CUER) has embarked on the first stage leading up to one of the greatest automotive challenges in the world. Their entry Mirage – which will shortly arrive in Australia – will have to endure a gruelling 3,000 km marathon from Darwin to Adelaide on 8th – 15th October 2017, facing some of the harshest conditions imaginable.
Mirage will be the seventh car designed and built by the CUER team, a group of 60 ambitious students from the University of Cambridge. Now celebrating their 10th anniversary, the team’s knowledge of automotive engineering and aerodynamics has enabled them to utilise cutting-edge technology to push the boundaries of what is possible for solar-powered cars.
Tony Purnell, Head of Technical Development at British Cycling and a member of CUER’s Steering Committee, comments that his endevours to achieve greater efficiency at British Cycling are not disimilar to that of the...
With the Bridgestone World Solar Challenge (BWSC) drawing closer, Cambridge University Eco Racing (CUER) has embarked on the first stage leading up to one of the greatest automo...
TTP will be exhibiting at The IJC.com, click here to read about our work in printing.
TheIJC brings together industry and academic leaders in their fields who speak about the latest advances and future developments driving digital print. It includes a focus on inkjet engineering, a review on fluid and ink components such as nano particles, conductive, aqueous and UV inks and an academic track open to all universities and non-commercial research institutes to present their work.
The IJC.com 4th Annual Inkjet Conference, 24-25 October 2017, Dussledorf
TTP plc, a leading technology and product development company, and New England Biolabs, Inc. (NEB®), an industry leader in the discovery and production of enzymes for molecular biology applications, today announce that they have established a non-exclusive partnership to offer services to molecular diagnostic technology developers. The new offering will include comprehensive product development services that span instrumentation, consumables and reagents.
The partnership is focused on supporting customers in the molecular diagnostic and wider life science space to rapidly transition ideas into commercially successful products. The services will couple NEB’s catalog of reagents and expertise in enzyme development and manufacturing with TTP’s Desktop Biology™ product development and physical engineering know-how, to provide capabilities that allow the delivery of more complete solutions, spanning from consumables and instrumentation through to reagents.
Dr. Giles Sanders, Consultant...
New offering will include integrated and comprehensive product development services for fast tracking innovation, progressing ideas into commercial products
TTP Plc (TTP), a leading independent technology and product development company, is seeking development and go-to-market partners for FormaJetTM, a novel printhead platform designed for true multi-colour bioprinting.
When commercialised, FormaJetTM will enable digital processing and bioprinting of molecules for deposition and dispensing. The technology can be tailored to suit TTP’s development partners’ specific market needs, with an initial demo configuration allowing easy loading of 96 colours from SBS plates. The platform is capable of addressing a broad range of reagent types from proteins, peptides and DNA, to low viscosity polymers, organic chemicals, volatile solvents and solid-loaded materials.
FormaJetTM has been conceived by a team which combines TTP’s expertise in diagnostics, drug discovery, and droplet-based digital printing. It will use droplet generation and control technology which has been proven in applications ranging from drug delivery to inkjet printing, and f...
Novel droplet dispensing concept will enable high-speed, high-density, many-colour printing in emerging applications including diagnostics, tissue engineering and drug discovery...
TTP Plc (TTP), a leading independent technology and product development company, today announced that it will be showcasing advances with the development of its Puckdx™ point-of-care diagnostic platform at the 69th AACC Annual Scientific Meeting and Clinical Lab Expo in San Diego, at booth 1658 at the San Diego Centre.
Since the launch of the platform at AACC in 2016, technical developments have made it possible for Puckdx to run quantitative PCR amplification times of 7 mins for 30 cycles. This will enable point-of-care diagnostic providers to rapidly convert their biological assay into a market-ready system capable of producing a result in less than quarter of an hour, for specific assays.
At its core, the Puck dx™ platform uses a novel fluid handling system designed to enable ready translation from bench to disposable. The platform has the flexibility to effectively and efficiently extract DNA and RNA from a range of samples. This, combined with an ultra-fast thermal cycler mod...
A flexible diagnostics platform that provides both rapid time to market and sample to result
TTP plc, Europe's leading technology and product development company, today announces its ongoing partnership with Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, to enable its rapid point-of-care diagnostics development program.
TTP’s Desktop Biology provides fast track development and rapid route to market for companies looking to commercialise their assays. Innova is providing custom magnetic beads and alkaline phosphatase conjugation services, to support the conjugate screening phases of TTP’s assay development.
The original custom project, under which Innova developed magnetic bead conjugation previously not offered either off-the-shelf or as a custom service, involved developing a range of magnetic beads of different diameters conjugated to capture antibodies. Innova produced all conjugates within 1 week of receiving antibody material. Following the success of this initial project the companies are planning to continue to collabor...
Enabling rapid point-of-care diagnostics
31st July to 3rd August 2017, San Diego Convention Centre, Booth 1658
TTP will be returning to AACC this year, if you would like to arrange a meeting with us at the event please contact email@example.com
InPrint is the exhibition for industrial print technology. Uniquely designed for print technology for manufacturing, the event has become the key marketplace in Europe for state of the art functional, decorative and packaging printing in industrial production.
And now, InPrint Show comes to the US for the first time, taking place April 25-27, 2017 in Orlando, Florida.
TTP will be showcasing FlexJet a fully modular industrial UV inkjet platform based around Ricoh’s GH2220 printhead.
25-27 April 2017
SATELLITE 2017 unites aerospace thought leaders, entrepreneurs, executives, engineers, end-users and enthusiasts together in one place for the largest and most important global satellite technology event of the year. For more than 35 years, SATELLITE has played a critical role in determining how satellites will shape the future of our world. The show welcomes a community of aerospace professionals from every market and field of study, hailing from more than 150 nations around the world.
From 2 inches to 20 thousand miles, TTP has it covered.
Visit us at booth #643 to find out what TTP can do for you.
7 - 9 March 2017, Washington, DC.
The Technology Partnership (TTP) has announced it is supporting an initiative in Cambridgeshire to help teachers with the new skills they need to teach coding to the next generation of learners. The idea is being led by David Anderson, a robotics/software expert and former employee at TTP, who has strong ties to the education sect...
TTP plc funds new robotics lessons to teach coding to teachers and students.
TTP Ventus formed to commercialise micropump technology.
Melbourn Science Park
SG8 6EE UK
Tel: +44 1763 262626
Fax: +44 1763 261582
Registered number: 3304950
Registered office: as shown above
Country of registration: England & Wales
VAT number: 636 9859 76
The Technology Partnership plc is a TTP Group plc company.
© 2018 The Technology Partnership. All rights reserved.